The mission of ACED Clinic Cambridge is to provide world-leading resources for all Alliance Centres to enable first-in-human clinical trials for early cancer detection to establish feasibility, acceptability and cost effectiveness of new diagnostics and early interventions.
Researchers across the Alliance can apply to work with the ACED Clinic Cambridge team, accessing a range of resources and facilities to accelerate the translation of early cancer detection tests into patient benefit. ACED Clinic Cambridge is hosted in the NIHR Cambridge Clinical Research Facility at Cambridge University Hospital.
- Resources include expertise in clinical project coordination, clinical trial statistics, health economics and the regulatory landscape. In addition to providing advice, our team includes research nurses and has the capacity to run single-centre trials.
- Facilities include consulting rooms, dedicated outpatient ward space, sample preparation rooms, a fully equipped procedure and endoscopy room, ultrasound equipment and a dark room for ex-vivo imaging.
Alongside supporting early-stage trials across the Alliance, ACED Clinic Cambridge will be recruiting volunteers into a pre-consented ACED Cohort with longitudinal data and sample capture for early detection studies that will be made accessible to the Alliance. More information to follow.
Existing trials that are working with ACED Clinic Cambridge include:
- PAN: Early detection of biomarkers in multiple cancers (Primary Contacts: Prof Rebecca Fitzgerald, Dr Marc van der Schee)
- ANTHCED: An anthropological study of the early detection of cancer (Primary contact: Dr Ignacia Arteaga)
- LEGACY: Longitudinal Evaluation of the Growth and Acquisition of Clones over Years in the blood (Primary contact: Dr Caroline Watson)
- DELTA: Cytosponge implementation research incorporating digital pathology and economic considerations (Primary Contact: Prof Rebecca Fitzgerald)
- PROSPERO: Prospective multicentre study to identify diagnostic key performance indicators in upper GI endoscopy (Primary Contact: Dr Massimiliano Di Pietro)
- ELECTRIC: Use of platelet transcriptomic signatures in the early detection of renal cell carcinoma (Primary Contact: Dr James Whitworth)
- EDUCAM: Early detection of neurological malignancy based on cognitive function and cfDNA (Primary Contact: Mr Rohit Sinha)
To discuss access to ACED Clinic Cambridge, please contact the Clinic Cambridge team in the first instance with a view to discussing your project prior completing this application form.